Faster. Easier. Better.
Breaking down barriers to test with decentralized molecular diagnostics.
We create a world where anyone can access quality diagnostics, anywhere, anytime. A world where individuals can access the care they need, and where prevention has become the standard.
374M
Sexually transmitted infections (STI’s) acquired worldwide every single year
2,8B
Tests performed for Chlamydia (CT) and gonorrhea (NG) infections every single year.
Current diagnostics are either slow & accurate or fast & unreliable, impacting patients, clinics and public health.
BioInovation Institute
Taking the Leap series
Founder Violette Defourt explains why we need to change the way we diagnose infectious diseases, and the significant improvements decentralized testing can offer patients and public health.
Rapidemic revolutionizes molecular diagnostics by combining speed and accuracy with ease-of-use, enabling a true decentralized and patient-centric testing experience, in clinics and at-home.
Healthcare practitioners
Timely diagnosis to guide treatment decisions and improved STI management.
Supported by
Featured in
